InMed Pharmaceuticals Inc (INM)

[SamL67]

Comparing mmj and what inmed is targeting is apples to oranges. if i understand inmeds approach--they have a way to identify which cannabaloids are most effective in treating a specific disease. smoking or injesting cannabis is a much broader approach--and especially when injesting-there are so many variables. smoking is not a delivery option of choice for many individuals seeking treatment. inmed also claims that their proprietary system will speed up the time (and reduced cost) from clinical trials to product approval. whether they can take what works in vitro and with mice to human application-and find a partner or funding source is another barrier. i guess its all about leadership and if you believe the braintrust can be as successful with cannabaloid based treatments as they were in previous pharmaceutical ventures. high risk-potential high reward.
sam